Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
Once home to the regional headquarters for telecommunications firm GTE, a long-vacant two-building office campus on U.S. 31 in Westfield is slated to get a new tenant.
California-based Carrington Mortgage Services said Thursday it plans to spend $3.2 million to open an office in Westfield. In addition to the new hires, about 180 employees in Fishers would move to the Westfield location.
Size and age complicate the sale of several prominent structures in Boone and Hamilton counties.
The home-improvement retail giant plans to hire 1,000 workers for the center at Intech Park on the northwest side. The jobs would pay an average hourly wage of about $16.
A Carmel-based institutional pharmacy plans to invest $8 million expanding its Noblesville operations, which include its headquarters. On Tuesday, it received its second tax-incentive deal from the city in two years.
Ohio-based Cardinal Health Inc. wants to open a $14.4 million drug-production facility that would employ 85 workers by 2017. A Cardinal subsidiary, Cardinal Health 414 LLC, produces a cancer treatment locally at a compounding center on Georgetown Road. The Indianapolis Department of Metropolitan Development said Cardinal wants to expand production of the medication by opening a second facility in an existing 64,000-square-foot warehouse at 4343 W. 62nd St. If the project goes forward locally, the company said it would spend $11.5 million to make the building suitable for pharmaceutical production and another $2.9 million in manufacturing and research equipment for the facility. Cardinal wants a tax abatement valued at $690,297 over 10 years. During that time, the company still would pay $648,169 in property taxes.
Consolidated Insurance Services Inc. has merged with Shepherd Insurance, creating an insurance agency with eight Indiana offices, 145 agents and more than 160 employees. Consolidated will now operate as Consolidated Shepherd Insurance, while Shepherd will maintain its name. Shepherd is based in Carmel and has offices in Noblesville, Greenfield, Columbus, Evansville and Seymour. The agency, which in recent years has bulked up its presence in health insurance, was founded in 1977 by Dave Shepherd, who won Indiana's Mr. Basketball award in 1970 while at Carmel High School. Consolidated, founded in 1932, is led by Rex Early, the former Republican state chairman and gubernatorial candidate.
Eli Lilly and Co. and a partner drugmaker won tentative regulatory approval for a once-a-day insulin that will compete with Lantus, the blockbuster insulin made by France-based Sanofi SA. Called Basaglar, the drug is approved for adults with type 2 diabetes and in combination with mealtime insulin for adults and children with type 1 diabetes. Lilly co-developed the drug with Germany-based Boehringer Ingelheim GmbH. The approval is tentative because of a claim of patent infringement filed by Sanofi. The U.S. Food and Drug Administration cannot give final approval of Basaglar until mid-2016, unless courts find in favor of Lilly earlier.
Eli Lilly and Co. will submit its experimental psoriasis drug for regulatory approval after the medicine helped six times as many patients participating in clinical trials completely clear up their skin irritations as an existing treatment. Lilly’s drug, ixekizumab, is in a race with two others to be first in a new class of psoriasis treatments to reach the market. Lilly expects to submit the drug to regulators—most likely in the United States, Europe and Japan—in the first half of 2015. The commercial prospects for ixekizumab are uncertain. Before Thursday’s announcements, Wall Street analysts expected the drug to fall short of $1 billion in annual sales by 2020. Switzerland-based Novartis AG already has submitted its drug for psoriasis to the FDA, and expects a decision as early as year’s end. California-based Amgen Inc. has partnered with United Kingdom-based Astra Zeneca plc on a new drug for psoriasis, but they have yet to complete late-stage testing.
Becknell Industrial LLC has proposed a $26 million, three-building development on the northwest side of Indianapolis that would be ready for tenants by early 2015.
A subsidiary of Dublin, Ohio-based Cardinal Health Inc. is seeking tax breaks from the city of Indianapolis to help it open a $14.4 million local drug-production facility that would employ 85 workers by 2017.
Aearo Technologies didn’t fulfill its job-creation promises under a 2007 tax abatement agreement with the city of Indianapolis, but it did spend nearly $16 million on buildings and equipment.
Local developer Reverie Estates is converting the administration building, now known as the Central State Mansion, into 67 dormitory-type rooms for student housing and welcomed its first tenant late last month.
The fast-growing local company, which already employs more than 200, plans to add up to 105 workers by 2024.
A Kansas City, Mo.-based developer has broken ground on a 740,000-square-foot distribution center in Lebanon, further juicing the Indy area’s status as a hot industrial market.
The 119,000-square-foot structure will be built next to the software developer’s headquarters on the northwest side as part of its growth plans to add 430 employees within the next few years.
The automaker filed a tax abatement request for the Bedford factory project, saying it would add about 40 jobs and raise the plant’s employment to some 650 workers.
Carmel City Council voted 6-0 Monday to terminate a tax abatement for Pharmakon LTC Pharmacy, which relocated its drug-repackaging operation to Noblesville last year.
Jarden Home Brands considered out-of-state sites for a new distribution center to serve its growing consumer-products business, but leaders opted to stay close to home. The Daleville-based company plans to move its headquarters to Fishers.
A subsidiary of the consumer products giant behind Ball jars, Yankee Candles, Crock-Pots and Coleman tents plans to spend nearly $22 million to open a regional headquarters and distribution center in Fishers that could employ nearly 300.
An unidentified company may take over a vacant distribution facility in Fishers, spurring town leaders to begin the process of making the property eligible for a tax abatement.
Workers will be hired as global firm Valeo buys new equipment for its 400,000-square-foot engine cooling factory to start new product lines for Honda, Nissan, Chrysler and Ford.
